title: Termination of Atherothrombosis Intervention in Metabolic Syndrome with Low High-Density Lipoprotein Cholesterol and High Triglycerides: Impact on Global Health Study and decision to use extended-release niacin in elderly.
authors.forename: Asit Baran
authors.initials: AB
authors.lastname: Shil
mesh_terms: D000368:Aged; D050197:Atherosclerosis / Q000188:drug therapy* / Q000209:etiology; D008076:Cholesterol, HDL / Q000097:blood; D003692:Delayed-Action Preparations; D057239:Early Termination of Clinical Trials; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D009525:Niacin / Q000627:therapeutic use*; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology; D014280:Triglycerides / Q000097:blood
chemical_list: D008076:Cholesterol, HDL; D003692:Delayed-Action Preparations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D014280:Triglycerides; D009525:Niacin